e184

e184 operates as a biotechnology research firm and an Advanced Research Funding Organization, dedicated to advancing frontier science and technology. The company primarily focuses on reproductive medicine, delving into fundamental biological processes and exploring life's symbiotic relationships. Its work aims to push boundaries in understanding where biological life originates and evolves.

Established in 2023, e184 was founded on an insight into the foundational principles of life, specifically targeting reproduction as a critical starting point. This understanding guides its biological research, seeking to comprehend and build upon the inherent logic that governs life's complexities and interconnected systems. The firm conducts its primary operations from Portland, Oregon.

Serving the scientific community through its research and funding initiatives, e184's vision extends to unraveling and applying life's deeper mechanisms. The company anticipates a future where enhanced comprehension of reproduction and symbiotic processes leads to significant advancements across scientific domains, fostering innovation by following life's inherent logic into new frontiers.